218 related articles for article (PubMed ID: 30554119)
21. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
[TBL] [Abstract][Full Text] [Related]
22. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
Platt VM; Szoka FC
Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
[TBL] [Abstract][Full Text] [Related]
23. Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation.
Salmani Javan E; Lotfi F; Jafari-Gharabaghlou D; Mousazadeh H; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2022 Feb; 23(2):519-527. PubMed ID: 35225464
[TBL] [Abstract][Full Text] [Related]
24. Unravelling the role of Silibinin in targeting CD44+ cancer stem cells: Therapeutic implications, effective strategies and approaches.
Lotia S; Patel S; Patel A; Patel V; Shah K; Tanavde V
Phytother Res; 2024 Apr; 38(4):1830-1837. PubMed ID: 38353369
[TBL] [Abstract][Full Text] [Related]
25. High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions.
Kim JE; Park YJ
Colloids Surf B Biointerfaces; 2017 Feb; 150():362-372. PubMed ID: 27823852
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
28. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract][Full Text] [Related]
29. Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells.
Shabani Ravari N; Goodarzi N; Alvandifar F; Amini M; Souri E; Khoshayand MR; Hadavand Mirzaie Z; Atyabi F; Dinarvand R
Daru; 2016 Jul; 24(1):21. PubMed ID: 27473554
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.
Hua H; Zhang N; Liu D; Song L; Liu T; Li S; Zhao Y
Int J Nanomedicine; 2017; 12():7869-7884. PubMed ID: 29123399
[TBL] [Abstract][Full Text] [Related]
31. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
[TBL] [Abstract][Full Text] [Related]
32. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
Yao HJ; Zhang YG; Sun L; Liu Y
Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
[TBL] [Abstract][Full Text] [Related]
33. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
34. Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.
Nascimento TL; Hillaireau H; Vergnaud J; Fattal E
Nanomedicine (Lond); 2016 Jul; 11(14):1865-87. PubMed ID: 27389568
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
36. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
[TBL] [Abstract][Full Text] [Related]
37. Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer.
Kommineni N; Saka R; Bulbake U; Khan W
Chem Phys Lipids; 2019 Nov; 224():104707. PubMed ID: 30521787
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
